Quality of Life With an Implanted Left Ventricular Assist Device

Moskowitz, Alan J.; Weinberg, Alan; Öz, Mehmet C.; Williams, Deborah

doi:10.1016/s0003-4975(97)01000-x

Cited by 85 publications

(74 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pump moves blood from the LV to aortic arch where it flows normally through the patient's arterial system. Short-term use of these devices in patients awaiting transplantation can maintain hemodynamics, improve vital organ function and exercise tolerance, allow patients to be discharged from the hospital, and provides them with a reasonable quality of life and a relatively low incidence of major adverse events (8)(9)(10)(11)(12)(13)(14)(15). Table 1 is showing a summary of some types of ventricular assist device.…”

Section: Ventricular Assist Devicesmentioning

confidence: 99%

Cardiac Compression Devices: Alternative Technology and Innovative Concept

Daliri

Yadollahi

Jadbabaei

2017

Multidiscip Cardio Annal

View full text Add to dashboard Cite

Heart failure is a leading cause of death around the world. Heart transplantation is the only reliable therapy for improving functional capacity, quality of life, life expectancy, and limiting the options for heart failure patients. In fact, a large number of patients with severe heart failure in need of heart transplantation are unable to receive therapy with up to 30% mortality before a heart is donated. In recent decades, cardiac replacement and assisting therapies have presented promising outcomes to treat these end-stage patients as alternative solutions. These devices are capable of providing temporary to permanent, partial or full assistance. Such devices can be divided into two categories based on location and mechanism of augmentation: 1) devices exposed directly to blood including ventricular assistive devices (VADs) and total artificial hearts (TAHs) and 2) devices that augment cardiac output through compression of ventricles or another part of circulatory system with no direct contact to blood such as extra-cardiac compression devices (ECCDs). In recent years, novel ECCDs which compress tissue and muscles to indirectly assist blood pumping have been developed to circumscribe problems associated with blood-contacting devices and the risks involved with piercing arterial and ventricular walls. Not only do ECCDs aim to reduce risks from the patient and surgeon perspective, the complexity of engineering an intra-corporeal extra-cardiac device is also reduced.

show abstract

Section: Ventricular Assist Devicesmentioning

confidence: 99%

Cardiac Compression Devices: Alternative Technology and Innovative Concept

Daliri

Yadollahi

Jadbabaei

2017

Multidiscip Cardio Annal

View full text Add to dashboard Cite

show abstract

“…One was specific to LVADs, 138 with the remaining two reporting utilities for ESHF patients 139,140 The studies are summarised in Table 33. A fuller discussion of these studies is presented in the section 'Cost-utility analyses', p. 80.…”

Section: Quantity Of Researchmentioning

confidence: 99%

“…In the study by Moskowitz and colleagues, 138 the SG asked patients told to compare (1) a hypothetical pill which would return them to full health versus (2) loss of their candidacy for transplantation or LVAD/relief of current symptoms (post-transplant group). In the study by Havrenak and colleagues, 139 TTO patients traded off their current health state with a return to full health; in the visual analogue scale (VAS) they were asked to rate their current health on a 10-cm line between 0 (death) and full health (1).…”

Section: Chaptermentioning

confidence: 99%

“…However, Moskowitz and colleagues 138 conducted a study which assessed the utilities of patients undergoing LVAD implantation as BTT. It was a comprehensive but small (n = 29) study conducted across all adult patients undergoing LVAD implantation at Columbia Presbyterian Medical Centre over an 18-month period.…”

Section: Heartmatementioning

confidence: 99%

“…Table 41 summarises the utility scores derived in these two studies and these appear to corroborate those reported by Moskowitz and colleagues. 138 The only economic evaluation based in the UK was undertaken by Christopher and Clegg 121 as 117,197 part of a systematic review of clinical and costeffectiveness of LVADs for ESHF. The study models the cost-utility associated with the use of the HeartMate and Novacor LVADs in the UK for the BTT indication.…”

Section: Moskowitz and Colleaguesmentioning

confidence: 99%

See 2 more Smart Citations

Cost–effectiveness of left ventricular-assist devices in end-stage heart failure

Hutchinson¹,

Scott²,

Clegg³

et al. 2008

Expert Review of Cardiovascular Therapy

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTAThe clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA Programme commissions research only on topics...

show abstract

Ventricular Assist Devices

Frazier

Parnis

2014

Textbook of Organ Transplantation

View full text Add to dashboard Cite

Quality of Life With an Implanted Left Ventricular Assist Device

Cited by 85 publications

References 10 publications

Cardiac Compression Devices: Alternative Technology and Innovative Concept

Cardiac Compression Devices: Alternative Technology and Innovative Concept

Cost–effectiveness of left ventricular-assist devices in end-stage heart failure

Ventricular Assist Devices

Contact Info

Product

Resources

About